Winner
Celgene
Judges’ comments
Celgene have shown real clarity in their submissions into PMEA this year. Their performance in the treatment of myeloma is impressive and they demonstrate clear focus on patient outcomes. As a company they collaborate effectively, internally and externally, achieving access for patients and delivering value for all.
